|
Volumn 9, Issue 6, 2008, Pages 463-464
|
Editorial: N-Acetyltransferases: Lessons learned from eighty years of research
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ARYLAMINE ACETYLTRANSFERASE;
ISONIAZID;
PHENYTOIN;
PROCAINAMIDE;
XENOBIOTIC AGENT;
DRUG;
ISOENZYME;
N ACETYLTRANSFERASE 1;
N-ACETYLTRANSFERASE 1;
NAT2 PROTEIN, HUMAN;
CANCER RISK;
CANCER SUSCEPTIBILITY;
DRUG ACETYLATION;
DRUG METABOLISM;
EDITORIAL;
ETHNIC DIFFERENCE;
GENETIC POLYMORPHISM;
GENETIC VARIABILITY;
GENOTYPE;
HUMAN;
LIVER TOXICITY;
NONHUMAN;
PHARMACOGENETICS;
PROTEIN STRUCTURE;
SINGLE NUCLEOTIDE POLYMORPHISM;
TOXICOGENETICS;
TRANSCRIPTION REGULATION;
TRANSLATION REGULATION;
TUBERCULOSIS;
UNSPECIFIED SIDE EFFECT;
ANIMAL;
CHEMISTRY;
GENETICS;
METABOLISM;
PHYSIOLOGY;
ANIMALS;
ARYLAMINE N-ACETYLTRANSFERASE;
HUMANS;
ISOENZYMES;
PHARMACEUTICAL PREPARATIONS;
|
EID: 47749126974
PISSN: 13892002
EISSN: None
Source Type: Journal
DOI: 10.2174/138920008784892146 Document Type: Editorial |
Times cited : (7)
|
References (24)
|